Skip to main content
Erschienen in: Osteoporosis International 7/2015

01.07.2015 | Case Report

A case report of osteomalacia unmasking primary biliary cirrhosis

verfasst von: M. Pawlowska, J. E. Kapeluto, D. L. Kendler

Erschienen in: Osteoporosis International | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Osteomalacia, a metabolic bone disease characterized by the inability to mineralize new osteoid, can be caused by vitamin D deficiency. We report a patient with symptomatic, biochemical, and imaging evidence of osteomalacia due to vitamin D deficiency, who as a result of work up for bone disease was diagnosed with early primary biliary cirrhosis. Osteomalacia was treated with high-dose vitamin D and serial bone density scans showed evidence of increasing bone mineral density suggesting osteoid mineralization in response to treatment. The diagnosis of cholestatic liver disease should be considered in all patients presenting with osteomalacia due to vitamin D deficiency, particularly if other cholestatic liver enzymes are elevated in addition to alkaline phosphatase.
Literatur
1.
Zurück zum Zitat Alola JF (2011) The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab 96:2987–2996CrossRef Alola JF (2011) The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab 96:2987–2996CrossRef
2.
Zurück zum Zitat Bingham CT, Fitzpatrick LA (1993) Noninvasive testing in the diagnosis of osteomalacia. Am J Med 195:519–523CrossRef Bingham CT, Fitzpatrick LA (1993) Noninvasive testing in the diagnosis of osteomalacia. Am J Med 195:519–523CrossRef
3.
Zurück zum Zitat Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501PubMedCrossRef Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501PubMedCrossRef
4.
Zurück zum Zitat Bhambri R, Naik V, Malhotra N et al (2006) Changes in bone mineral density following treatment of osteomalacia. J Clin Densitom 9:120–127PubMedCrossRef Bhambri R, Naik V, Malhotra N et al (2006) Changes in bone mineral density following treatment of osteomalacia. J Clin Densitom 9:120–127PubMedCrossRef
5.
Zurück zum Zitat Collier JD, Ninkovic M, Compston JE (2002) Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50(Suppl 1):i1–i9PubMedCentralPubMedCrossRef Collier JD, Ninkovic M, Compston JE (2002) Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50(Suppl 1):i1–i9PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Guanabens N, Pares A, Ros I et al (2005) Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 42:573–577PubMedCrossRef Guanabens N, Pares A, Ros I et al (2005) Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 42:573–577PubMedCrossRef
8.
Zurück zum Zitat Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351:805–806PubMedCrossRef Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351:805–806PubMedCrossRef
9.
Zurück zum Zitat Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693PubMed Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693PubMed
10.
Zurück zum Zitat Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER (1995) Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 21:389–392PubMed Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER (1995) Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 21:389–392PubMed
11.
Zurück zum Zitat Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913–921PubMedCrossRef Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913–921PubMedCrossRef
12.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder. Kidney Int Suppl 113:S1–S130 Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder. Kidney Int Suppl 113:S1–S130
Metadaten
Titel
A case report of osteomalacia unmasking primary biliary cirrhosis
verfasst von
M. Pawlowska
J. E. Kapeluto
D. L. Kendler
Publikationsdatum
01.07.2015
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 7/2015
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-015-3102-5

Weitere Artikel der Ausgabe 7/2015

Osteoporosis International 7/2015 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.